Почетна › Немалоклетни карцином плућа › Северна Каролина › Durham
Kliničke studije za Немалоклетни карцином плућа u gradu Durham, NC
42 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u gradu Durham i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Тражи се учесникФаза 3
- Duke University Medical Center Duke Cancer Center, Durham
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Тражи се учесникФаза 1/2
- Duke Cancer Center Durham, Durham
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Тражи се учесникФаза 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Тражи се учесникФаза 3
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Тражи се учесникФаза 3
- Duke University Medical Center, Durham
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
Тражи се учесникФаза 1
- Duke University Medical Center, Durham
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Тражи се учесникФаза 3
- UNC Lineberger Comprehensive Cancer Center ( Site 3250), Chapel Hill · 10 ми удаљено
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Тражи се учесникФаза 1/2
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10 ми удаљено
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Тражи се учесникФаза 1
- Duke Health - Duke University Hospital, Durham
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Тражи се учесникФаза 2
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 ми удаљено
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Тражи се учесникФаза 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 ми удаљено
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Тражи се учесникФаза 2
- UNC Health - University of North Carolina, Chapel Hill · 10 ми удаљено
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Тражи се учесникФаза 3
- Durham VA Health Care System, Durham
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Тражи се учесникФаза 2/3
- Duke University Medical Center, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Тражи се учесникФаза 1
- Research Site, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Тражи се учесник
- Durham VA Medical Center, Durham, NC, Durham
TOP 2301: Neoadjuvant Chemo for NSCLC
Тражи се учесникФаза 2
- Duke University, Durham
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Тражи се учесникФаза 1/2
- Duke University School of Medicine, Durham
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Тражи се учесникФаза 3
- Duke University, Durham
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Тражи се учесникФаза 3
- Durham Veterans Affairs Health Care System, Durham
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Тражи се учесникФаза 1/2
- Duke Cancer Institute, Durham
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Тражи се учесникФаза 2/3
- Durham VA Medical Center, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Duke University, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Тражи се учесникФаза 1
- Exelixis Clinical Site #12, Durham
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Тражи се учесникФаза 3
- Duke Cancer Center, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
Тражи се учесникФаза 1
- PHN-012-001 Site, Durham
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Тражи се учесникФаза 3
- Clinical Study Site, Durham
- Clinical Study Site, Chapel Hill · 10 ми удаљено
Effects of Infusion Timing on Treatment Response in Solid Tumors
Тражи се учесникФаза 2
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 ми удаљено
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Тражи се учесникОпсервациона студија
- UNC- Chapel Hill, Chapel Hill · 10 ми удаљено
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Тражи се учесникФаза 1
- Duke Cancer Institute, Durham
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Тражи се учесникФаза 1
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill · 10 ми удаљено
- University of North Carolina, Chapel Hill · 10 ми удаљено
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Duke Cancer Center, Durham
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Тражи се учесникФаза 2
- University of North Carolina, Chapel Hill · 10 ми удаљено
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Тражи се учесникФаза 1
- Duke Cancer Institute /ID# 276267, Durham
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Тражи се учесникФаза 1
- Duke Cancer Center /ID# 251975, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Тражи се учесникФаза 1
- Duke Cancer Center, Durham
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Тражи се учесникФаза 2
- Durham VA Medical Center, Durham
GEMINI-NSCLC: NSCLC Biomarker Study
Тражи се учесникОпсервациона студија
- Duke University, Durham
- UNC, Chapel Hill · 10 ми удаљено
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 ми удаљено
A Study of NX-1607 in Adults With Advanced Malignancies
Тражи се учесникФаза 1
- University of North Carolina, Chapel Hill · 10 ми удаљено
Studije za Немалоклетни карцином плућа u drugim gradovima
- Houston, TX143 студија
- New York City, NY123 студија
- Arlington, VA111 студија
- Nashville, TN97 студија
- Los Angeles, CA92 студија
- Boston, MA87 студија
- St. Louis, MO68 студија
- Baltimore, MD60 студија
- San Antonio, TX60 студија
- Chicago, IL59 студија
- Columbus, OH57 студија
- Seattle, WA55 студија
Ostale studije u gradu Durham
- Рак дојке63 студија
- Рак (све врсте)61 студија
- Многи мијелом36 студија
- Akutna mijeloidna leukemija34 студија
- Рак плућа33 студија
- Метастатски карцином33 студија
- Рак простате32 студија
- Колоректални карцином30 студија
- Рак јајника28 студија
- Hronična limfocitna leukemija28 студија
- Затајење срца25 студија
- Рак панкреаса24 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.